Gene · 4068
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virological Markers in Epstein-Barr Virus-Associated Diseases. | Viruses | 2023 | 36992365 | PubTator, text mining | PubMed |
Study protocol for a randomised controlled trial to evaluate the use of melanoma surveillance photography to the Improve early detection of MelanomA in ultra-hiGh and high-risk patiEnts (the IMAGE trial). | Trials | 2023 | 36991460 | PubTator, text mining | PubMed |
| [Advances in the treatment of CD30 positive lymphoma with brentuximab vedotin]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 36987732 | PubTator, text mining | PubMed |
| Secondary Anterior Cruciate Ligament Injury Prevention Training in Athletes: What Is the Missing Link? | Int J Environ Res Public Health | 2023 | 36981735 | PubTator, text mining | PubMed |
| The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies. | Cancers (Basel) | 2023 | 36980798 | PubTator, text mining | PubMed |
| Effects of Malocclusion on Maximal Aerobic Capacity and Athletic Performance in Young Sub-Elite Athletes. | Sports (Basel) | 2023 | 36976957 | PubTator, text mining | PubMed |
| Eighteen Novel Bioactive Peptides from Monkfish (Lophius litulon) Swim Bladders: Production, Identification, Antioxidant Activity, and Stability. | Mar Drugs | 2023 | 36976218 | PubTator, text mining | PubMed |
| Simple Complexity: Incorporating Bioinspired Delivery Machinery within Self-Assembled Peptide Biogels. | Gels | 2023 | 36975648 | PubTator, text mining | PubMed |
| Editorial: Primary immune regulatory disorders: Coming of age. | Front Pediatr | 2023 | 36969275 | PubTator, text mining | PubMed |
| Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis. | Front Immunol | 2023 | 36969238 | PubTator, text mining | PubMed |
| ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. | Cell Death Dis | 2023 | 36966163 | PubTator, text mining | PubMed |
| The transcription factor Mef2d regulates B:T synapse-dependent GC-TFH differentiation and IL-21-mediated humoral immunity. | Sci Immunol | 2023 | 36961907 | PubTator, text mining | PubMed |
| Diversity of immune checkpoints in cancer immunotherapy. | Front Immunol | 2023 | 36960057 | PubTator, text mining | PubMed |
| A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer. | iScience | 2023 | 36950120 | PubTator, text mining | PubMed |
| Predictive Risk Factors of Pancreatic Exocrine Insufficiency Developed After Acute Pancreatitis: A Retrospective Cohort Study. | J Inflamm Res | 2023 | 36950051 | PubTator, text mining | PubMed |
| The first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022. | Osong Public Health Res Perspect | 2023 | 36944341 | PubTator, text mining | PubMed |
| Postpartum fevers, a rare presentation of secondary hemophagocytic lymphohistiocytosis. | Clin Case Rep | 2023 | 36941837 | PubTator, text mining | PubMed |
| A critical analysis of walking policy in Ireland and its contribution to both national and international development goals. | Front Sports Act Living | 2023 | 36935882 | PubTator, text mining | PubMed |
| Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO). | Trials | 2023 | 36934272 | PubTator, text mining | PubMed |
| IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 36930079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4068/papers?page=31